Clinical Benefit
| Moderate |
Le service médical rendu par cette spécialité est modéré dans l’hypertrophie bénigne de la prostate non compliquée.
|
Clinical Added Value
| no clinical added value |
OMEXEL LP 0,4mg (gel matriciel) n’apporte pas d’amélioration du service.
|
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
TnKvKKuTN7YESA4P